Incorporating new criteria can improve the ability of CEUS LI-RADS to differentiate HCC from non-HCC malignancies

Rong Wen1, Yuting Peng1,2, Ruizhi Gao1

  • 1Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

PubMed

Insights

A new criterion for early washout in contrast-enhanced ultrasound (CEUS) LI-RADS can improve the differentiation of hepatocellular carcinoma (HCC) from other liver malignancies. This modification enhances diagnostic accuracy for high-risk patients.

Area of Science:

  • Hepatobiliary imaging
  • Diagnostic radiology
  • Oncology

Background:

  • Hepatocellular carcinoma (HCC) diagnosis relies on imaging.
  • Contrast-enhanced ultrasound (CEUS) with LI-RADS criteria is crucial for HCC risk stratification.
  • Distinguishing HCC from other malignant liver lesions can be challenging.

Purpose of the Study:

  • To evaluate the diagnostic performance of CEUS LI-RADS.
  • To enhance the differentiation between HCC and non-HCC malignancies by modifying LR-M criteria.

Main Methods:

  • Retrospective analysis of CEUS examinations in high-risk HCC patients.
  • Reassessment of LR-M lesions using modified criteria, focusing on early washout timing.
  • Comparison of diagnostic efficacy across four distinct early washout criteria.

Main Results:

  • Modified criteria, particularly 'washout onset-enhancement onset < 30 s' (Criterion 4), showed improved sensitivity for HCC detection compared to earlier criteria.
  • Specificities and positive predictive values (PPVs) remained high across most modified criteria, with Criterion 1 showing the highest specificity.
  • Criterion 2 demonstrated higher sensitivity but significantly lower specificity and PPV.

Conclusions:

  • The proposed new criterion for early washout (washout onset-enhancement onset < 30 s) shows promise for improving HCC differentiation.
  • Refining CEUS LI-RADS criteria can enhance diagnostic accuracy in distinguishing HCC from non-HCC malignancies.
  • Further validation of modified LR-M criteria is warranted for clinical application.
Abstract